HALO
USDHalozyme Therapeutics Inc. Common Stock
$68.050+0.410 (0.606%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$67.640
High
$69.910
Low
$65.000
Volume
0.89M
Company Fundamentals
Market Cap
8.0B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.09M
Exchange
NMS
Currency
USD
52-Week Range
Low $42.01Current $68.050High $79.5
Related News
Analyst Upgrades
JP Morgan Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $65
JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics with a Neutral and raises the price target from $63 to $65.
View more
Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $90 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Halozyme Therapeutics with a Buy and maintains $90 price target.
View more
Analyst Upgrades
Leerink Partners Upgrades Halozyme Therapeutics to Market Perform, Announces $70 Price Target
Leerink Partners analyst David Risinger upgrades Halozyme Therapeutics from Underperform to Market Perform and announces $70 price target.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.